AI should excel at competitive intelligence tracking, so I decided to test how well current platforms perform on a real-world example: mapping the obesity drug development pipeline. My goal was to create a comprehensive table of all obesity drugs in Phase 2 and Phase 3 clinical trials in the US (excluding agents being developed exclusively in China or other Asian markets). Methodology First, I manually compiled a reference table using traditional research methods—reviewing Cl

Introduction One of the current administration's goals is to remove or at least restrict pharmaceutical direct-to-consumer (DTC)...

Success in oncology remains one of the most meaningful and competitive achievements in BioPharma. Over the past decade, checkpoint...

When we think of measles, we typically think of an itchy rash but in fact measles is a respiratory infection with rash being one of the...

Figure 1  US rates of CIN2+ lesions by age group, adapted from Gargano et al 2019 The Human Papilloma Virus (HPV) vaccine...

How do companies decide what color a pill should be?

Competition and the introduction of biosimilars introduce challenges in drug development.

New -bart stem to be used for monoclonal antibody INNs.